Link to this page
Physician Data Query
Preferred Name | eicosapentaenoic acid | |
Synonyms |
all cis-5,8,11,14,17-eicosapentaenoic acid IPA timnodonic acid icosapentaenoic acid EPA |
|
Definitions |
An essential, polyunsaturated, 20-carbon omega-3 fatty acid with anti-inflammatory and potential antineoplastic and chemopreventive activities. Eicosapentaenoic acid (EPA) may activate caspase 3, resulting in apoptosis in susceptible tumor cell populations. In addition, this agent may inhibit cyclooxygenase-2 (COX-2), resulting in inhibition of prostaglandin synthesis and prostaglandin-mediated inflammatory processes. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C67080" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C67080" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000537376 |
|
altLabel |
all cis-5,8,11,14,17-eicosapentaenoic acid IPA timnodonic acid icosapentaenoic acid EPA
|
|
cui |
C0000545
|
|
DATE FIRST PUBLISHED |
2007-02-16
|
|
Date last modified |
2008-04-24
|
|
definition |
An essential, polyunsaturated, 20-carbon omega-3 fatty acid with anti-inflammatory and potential antineoplastic and chemopreventive activities. Eicosapentaenoic acid (EPA) may activate caspase 3, resulting in apoptosis in susceptible tumor cell populations. In addition, this agent may inhibit cyclooxygenase-2 (COX-2), resulting in inhibition of prostaglandin synthesis and prostaglandin-mediated inflammatory processes. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C67080" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C67080" NCI Thesaurus)
|
|
NCI ID |
C67080
|
|
notation |
CDR0000537376
|
|
ORIG STY |
Drug/agent
|
|
prefLabel |
eicosapentaenoic acid
|
|
tui |
T109 T123 T121
|
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |